Board Member
Sagimet Biosciences Inc. (SGMT)Equibles does not estimate personal net worth.
Get an email with a short summary when Sagimet Biosciences Inc. publishes a filing, an earnings call transcript or a press release.
Get SGMT alertsDavid Happel is recorded as CEO and Board Member at Sagimet Biosciences Inc. (SGMT). The newest filing on record that lists David Happel as CEO and Board Member at Sagimet Biosciences Inc. (SGMT) is dated April 21, 2026. The proxy statement of Sagimet Biosciences Inc. reports total compensation of $3,239,994 for David Happel in fiscal 2025, including a base salary of $630,000. Disclosed compensation is on record for 4 fiscal years. David Happel has spoken on 1 investor event across 1 company, most recently for Sagimet Biosciences Inc. on August 11, 2026. Sagimet Biosciences Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Sagimet Biosciences Inc. includes George Kemble (Chairman and Board Member), Anthony Rimac (CFO and Chief Accounting Officer), Dennis Hom (CFO) and 7 others.
“So we're a, Sagumet is a clinical stage biopharmaceutical company, and our focus really is on understanding how fatty acid synthase or FASN, or I should say overexpression or overactivity of FASN plays such a critical role in the development of a number of underserved conditions with our lead program being in acne.”
Start not stated–present
Last confirmed April 21, 2026
Start not stated–present
Last confirmed April 21, 2026
Biotechnology · Healthcare
CEO, Board Member
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Sagimet Biosciences Inc. (SGMT) | President and Chief Executive Officer | $630,000 | $3,239,994 |
| 2024 | Sagimet Biosciences Inc. (SGMT) | President and Chief Executive Officer | $582,000 | $906,164 |
| 2023 | Sagimet Biosciences Inc. (SGMT) | President and Chief Executive Officer | $502,894 | $2,685,917 |
| 2022 | Sagimet Biosciences Inc. (SGMT) | President and Chief Executive Officer | $97,917 | $6,508,193 |
